Analysis of the Variables Influencing Valproic Acid Concentration in the Serum and Cerebrospinal Fluid of Chinese Patients After Craniotomy

被引:5
作者
Li, Zhihong [1 ,2 ]
Gao, Weiqi [2 ]
Liu, Guifen [1 ]
Chen, Weihong [2 ]
机构
[1] Shanxi Med Univ, Sch Publ Hlth, Dept Hlth Stat, Taiyuan, Peoples R China
[2] Shanxi Med Univ, Affiliated Da Yi Hosp, Shanxi Da Yi Hosp, Dept Pharm, 99 Longcheng St, Taiyuan 030032, Peoples R China
关键词
valproic acid; cerebrospinal fluid; therapeutic drug monitoring; gender; CYP2C9; UGT1A6; BLOOD-BRAIN-BARRIER; ANTIEPILEPTIC DRUG-RESISTANCE; PLASMA-CONCENTRATIONS; MULTIDRUG-RESISTANCE; MONITORING DATA; ELDERLY-PEOPLE; P-GLYCOPROTEIN; STEADY-STATE; EPILEPSY; PHARMACOKINETICS;
D O I
10.1097/FTD.0000000000000424
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BACKGROUND: Valproic acid (VPA) has been widely used in Chinese patients after craniotomy. Many studies have focused on the influencing factors of VPA serum concentration, but conclusions are sometimes paradoxical. Furthermore, the concentration of VPA in the cerebrospinal fluid (CSF) has been rarely reported. In the present study, VPA CSF concentrations were measured, and the potential factors influencing serum concentration and CSF distribution of VPA were investigated. In addition, the functional relationship between serum and CSF concentration was explored. METHODS: Subjects were patients who underwent craniotomy and were administrated with VPA and had a lumbar puncture. Serum and CSF VPA concentrations were measured by use of the Abbott i1000 system. CYP2C9 (430 C>T, 1075 A>C, 1076 T>C, 1080 C>G), UGT1A6 (541 A>G, 552 A>C), UGT2B7 (211 G>T, 802 C>T), and ABCB1 (1236 C>T, 2677 G>T/A, 3435 C>T) genotypes were determined by direct sequencing. Information, such as age, gender, and height, was collected, and their effect on serum and CSF VPA concentrations was investigated by univariate analysis and multiple linear regression analysis. RESULTS: First, the concomitant use of carbapenems (beta' = -0.422) and UGT1A6 (552 AA -> AC) (beta' = -0.249) had a significant negative correlation with the weight-adjusted VPA serum concentration (C:W ratio), whereas CYP2C9 (1075 AA -> AC) (beta' = 0.186) and gender (female compared with male) (beta' = 0.322) showed a positive correlation with VPA serum C:W ratio. The coefficient of determination (R) was only 0.348. Second, the relationship between the serum concentration and the CSF square root of the concentration (R-2 = 0.705) had a better linear fit. Third, serum VPA concentration (beta' = 0.810), concomitant use of glycerol fructose (beta' = 0.160), and age (>= 65 compared with <65) (beta' = 0.118) showed a positive correlation (R-2 = 0.748) with the variability of square root of the concentration of the CSF. CONCLUSIONS: In Chinese patients, after craniotomy, female patients with 1 or more of CYP2C9 (1075 AC) and UGT1A6 (552 AA) genotypes required a lower VPA dosage compared with male patient. There was a better-fitted linear relationship between VPA serum and the square root of CSF concentrations. CSF VPA concentrations were relatively stable, with only age and the use of glycerol fructose having a small influence.
引用
收藏
页码:450 / 456
页数:7
相关论文
共 50 条
  • [41] Serum sex hormone levels in young male patients with epilepsy receiving carbamazepine and valproic acid and after their withdrawal
    Alberto Verrotti
    Fania Basciani
    Simona Morresi
    Rocco Cutarella
    Guido Morgese
    Francesco Chiarelli
    [J]. European Journal of Pediatrics, 2000, 159 : 871 - 872
  • [42] Elevated lysophosphatidic acid levels in the serum and cerebrospinal fluid in patients with multiple sclerosis: therapeutic response and clinical implication
    Jiang, Dongxiao
    Ju, Weiping
    Wu, Xijun
    Zhan, Xia
    [J]. NEUROLOGICAL RESEARCH, 2018, 40 (05) : 335 - 339
  • [43] The added value of cerebrospinal fluid analysis in patients with subarachnoid hemorrhage after negative noncontrast CT
    van den Berg, Rene
    Jeung, Lung
    Post, Rene
    Coert, Bert A.
    Hoogmoed, Jantien
    Coutinho, Jonathan M.
    Majoie, Charles B.
    Verbaan, Dagmar
    Emmer, Bart J.
    Vandertop, William P.
    [J]. JOURNAL OF NEUROSURGERY, 2022, 136 (04) : 1024 - 1028
  • [44] Cerebrospinal Fluid Free Fatty Acid Levels Are Associated with Stroke Subtypes and Severity in Chinese Patients with Acute Ischemic Stroke
    Sun, Guo-Ju
    Ding, Su-Chun
    Ling, Wen-Yuan
    Wang, Fang
    Yang, Xiao-Ping
    [J]. WORLD NEUROSURGERY, 2015, 84 (05) : 1299 - 1304
  • [45] Cerebrospinal fluid/serum albumin ratio in patients with Lewy body disease: a systematic review and meta-analysis
    Li, Moyu
    Gan, Jinghuan
    Yang, Xia
    Liu, Shuai
    Ji, Yong
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
  • [46] Comparative Analysis of Cytokine Profiles in Cerebrospinal Fluid and Blood Serum in Patients with Acute and Subacute Spinal Cord Injury
    Sabirov, Davran
    Ogurcov, Sergei
    Shulman, Ilya
    Kabdesh, Ilyas
    Garanina, Ekaterina
    Sufianov, Albert
    Rizvanov, Albert
    Mukhamedshina, Yana
    [J]. BIOMEDICINES, 2023, 11 (10)
  • [47] Functional and proteomic analysis of serum and cerebrospinal fluid derived from patients with traumatic brain injury: a pilot study
    Cadosch, Dieter
    Thyer, Matthew
    Gautschi, Oliver P.
    Lochnit, Guenter
    Frey, Soenke P.
    Zellweger, Rene
    Filgueira, Luis
    Skirving, Allan P.
    [J]. ANZ JOURNAL OF SURGERY, 2010, 80 (7-8) : 542 - 547
  • [48] CEREBROSPINAL-FLUID AS A TOOL IN THE DIAGNOSIS OF NEUROMETABOLIC DISEASES - AMINO-ACID-ANALYSIS BEFORE AND AFTER ACID-HYDROLYSIS
    JAEKEN, J
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1994, 153 (07) : S86 - S89
  • [49] Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: A Phase 1 study
    Curtin, Francois
    Vidal, Virginie
    Bernard, Corinne
    Kromminga, Arno
    Lang, Alois B.
    Porchet, Herve
    [J]. MABS, 2016, 8 (05) : 854 - 860
  • [50] Label-free Quantitative Proteomic Analysis of Cerebrospinal Fluid and Serum in Patients With Relapse-Remitting Multiple Sclerosis
    Liu, Haijie
    Wang, Ziwen
    Li, He
    Li, Meijie
    Han, Bo
    Qi, Yuan
    Wang, Huailu
    Gao, Juan
    [J]. FRONTIERS IN GENETICS, 2022, 13